We provide a portfolio of preclinical and clinical development and commercial
service offerings — delivered through industry-leading nonclinical testing services,
a global team of clinical trial professionals.
Our CEO and senior consultants have for being on the fore front of the Clinical
Development process. They have rendered there services to clients CROs viz;
- Forest Labs
We base our experience working with these clients and develop clinical development
tools & solutions , using our innovative process. Our efforts enable us to speed
up the accountablity & compliance process in this industry.
Once early development studies are completed, the information
learned from this process allows a pharmaceutical company to make the next critical
decision: Should the company proceed with the clinical development of a therapeutic
SolutionsMax has helped numerous clients successfully manage the transition from
nonclinical to Phase I and IIa clinical studies, enabling them to make effective
and fast decisions about the safety and efficacy of their compounds.
The next step — initiation of Phase IIb and Phase III clinical trials — is a complex
undertaking and represents an enormous commitment of resources. To manage projects
of this magnitude, SolutionsMax draws on its broad knowledge and experience, from
clinical trial service design and execution to the preparation and submission of
data to regulatory authorities in multiple countries.
With clinical trial service experts located in our offices worldwide, SolutionsMax
has one of the most experienced teams devoted exclusively to Phase II and III clinical
trials. This includes numerous specialized services that support clinical development,
- Interactive Voice Response Services
- Cardiac Safety Services
- Centralized cardiac safety services
- Bioanalytical chemistry.
- Medical Devices Evaluations